New Zealand markets close in 3 hours 37 minutes

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.7100-0.1500 (-3.09%)
At close: 04:00PM EDT
4.8200 +0.11 (+2.34%)
After hours: 07:58PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.10M
Enterprise value 974.50k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.37
Enterprise value/revenue N/A
Enterprise value/EBITDA -2.21

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-96.52%
S&P500 52-week change 323.33%
52-week high 3141.7500
52-week low 33.9400
50-day moving average 35.9291
200-day moving average 320.0712

Share statistics

Avg vol (3-month) 3228.93k
Avg vol (10-day) 3102.94k
Shares outstanding 5834.9k
Implied shares outstanding 6834.9k
Float 8823.54k
% held by insiders 10.75%
% held by institutions 11.37%
Shares short (15 May 2024) 414.85k
Short ratio (15 May 2024) 40.03
Short % of float (15 May 2024) 41.78%
Short % of shares outstanding (15 May 2024) 41.78%
Shares short (prior month 15 Apr 2024) 446.08k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 326 Apr 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-11.58%
Return on equity (ttm)-180.17%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -12.64M
Net income avi to common (ttm)-105.53M
Diluted EPS (ttm)-958.3500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.03M
Total cash per share (mrq)2.44
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)0.30
Book value per share (mrq)13.44

Cash flow statement

Operating cash flow (ttm)-7.91M
Levered free cash flow (ttm)-4.93M